Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PLASMA PROTEIN THERAPEUTICS INDUSTRY
2.1 Summary about Plasma Protein Therapeutics Industry
2.2 Plasma Protein Therapeutics Market Trends
2.2.1 Plasma Protein Therapeutics Production & Consumption Trends
2.2.2 Plasma Protein Therapeutics Demand Structure Trends
2.3 Plasma Protein Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Coagulation Factor
4.2.2 Immune Globulin
4.2.3 Albumin
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hemophilia
4.3.2 PID
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Coagulation Factor
5.2.2 Immune Globulin
5.2.3 Albumin
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hemophilia
5.3.2 PID
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Coagulation Factor
6.2.2 Immune Globulin
6.2.3 Albumin
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hemophilia
6.3.2 PID
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Coagulation Factor
7.2.2 Immune Globulin
7.2.3 Albumin
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hemophilia
7.3.2 PID
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Coagulation Factor
8.2.2 Immune Globulin
8.2.3 Albumin
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hemophilia
8.3.2 PID
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Coagulation Factor
9.2.2 Immune Globulin
9.2.3 Albumin
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hemophilia
9.3.2 PID
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Shire (Baxalta)
10.1.2 CSL
10.1.3 Grifols
10.1.4 Octapharma
10.1.5 Kedrion
10.1.6 LFB Group
10.1.7 Biotest
10.1.8 BPL
10.1.9 RAAS
10.1.10 CBPO
10.1.11 Hualan Bio
10.1.12 Kamada
10.2 Plasma Protein Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Shire (Baxalta)
10.2.2 CSL
10.2.3 Grifols
10.2.4 Octapharma
10.2.5 Kedrion
10.2.6 LFB Group
10.2.7 Biotest
10.2.8 BPL
10.2.9 RAAS
10.2.10 CBPO
10.2.11 Hualan Bio
10.2.12 Kamada
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Plasma Protein Therapeutics Product Type Overview
2.Table Plasma Protein Therapeutics Product Type Market Share List
3.Table Plasma Protein Therapeutics Product Type of Major Players
4.Table Brief Introduction of Shire (Baxalta)
5.Table Brief Introduction of CSL
6.Table Brief Introduction of Grifols
7.Table Brief Introduction of Octapharma
8.Table Brief Introduction of Kedrion
9.Table Brief Introduction of LFB Group
10.Table Brief Introduction of Biotest
11.Table Brief Introduction of BPL
12.Table Brief Introduction of RAAS
13.Table Brief Introduction of CBPO
14.Table Brief Introduction of Hualan Bio
15.Table Brief Introduction of Kamada
16.Table Products & Services of Shire (Baxalta)
17.Table Products & Services of CSL
18.Table Products & Services of Grifols
19.Table Products & Services of Octapharma
20.Table Products & Services of Kedrion
21.Table Products & Services of LFB Group
22.Table Products & Services of Biotest
23.Table Products & Services of BPL
24.Table Products & Services of RAAS
25.Table Products & Services of CBPO
26.Table Products & Services of Hualan Bio
27.Table Products & Services of Kamada
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Plasma Protein Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Plasma Protein Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Plasma Protein Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Plasma Protein Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f